Gérard Ber
Director/Board Member chez Y-MABS THERAPEUTICS, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Gérard Ber is the founder of Advanced Accelerator Applications SA, which was founded in 2002.
He held the position of Chief Operating Officer from 2014 to 2018.
Currently, he holds multiple positions, including Director at Lantheus Medical Imaging, Inc. and Independent Director at Lantheus Holdings, Inc., Y-mAbs Therapeutics, Inc., CUTISS AG, and Evergreen Theragnostics, Inc. He is also a Director at Advanced Accelerator Applications (UK & Ireland) Ltd.
Dr. Ber previously held the position of Independent Director at Progenics Pharmaceuticals, Inc. from 2019 to 2020.
He also held positions at CIS Bio International SA and OM Pharma SA. Dr. Ber received his graduate and doctorate degrees from Université Joseph Fourier in 1984 and his undergraduate degree from Institut de Pharmacie Industrielle de Paris in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTHEUS HOLDINGS INC
0,05% | 11/05/2023 | 32 535 ( 0,05% ) | 2 M $ | 31/03/2024 |
| 08/06/2023 | 58 773 ( 0,13% ) | 955 649 $ | 31/03/2024 |
Postes actifs de Gérard Ber
| Sociétés | Poste | Début |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Director/Board Member | 11/12/2018 |
| LANTHEUS HOLDINGS, INC. | Director/Board Member | 19/06/2020 |
Advanced Accelerator Applications (UK & Ireland) Ltd.
 Advanced Accelerator Applications (UK & Ireland) Ltd. Medical SpecialtiesHealth Technology Imaging Equipment Ltd. distributes medical technologies. The firm offers PET and nuclear medical, imaging equipment, radiotherapy products, diagnostic imaging, radiation safety quality assurance, medical phantoms, ultrasound quality assurance products, molecular imaging, radiology tables, and bone densitometry products for the purpose of diagnosing osteoporosis. The company was founded in 2001 and is headquartered in Somerset, the United Kingdom. | Director/Board Member | - |
Evergreen Theragnostics, Inc.
 Evergreen Theragnostics, Inc. BiotechnologyHealth Technology Evergreen Theragnostics, Inc. manufactures and develops radiopharmaceuticals. It offers 21 CFR 211 compliant commercial manufacturing, nationwide logistics and distribution, technology transfer and method validation and regulatory support services. The company was founded in 2019 and is headquartered in Jersey City, NJ. | Director/Board Member | - |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Director/Board Member | 01/06/2020 |
CUTISS AG
 CUTISS AG Medical SpecialtiesHealth Technology CUTISS AG develops bioengineered skin grafts to heal people with skin defects. The company was founded by Ernst Reichmann, Martin Meuli, Daniela Marino, Clemens Schiestl and Fabienne Hartmann-Fritsch and is headquartered in Zurich, Switzerland. | Director/Board Member | 28/05/2020 |
Anciens postes connus de Gérard Ber
| Sociétés | Poste | Fin |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 19/06/2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Founder | 01/01/2018 |
OM Pharma SA
 OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Sales & Marketing | - |
| ░░░ ░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Gérard Ber
| Université Joseph Fourier | Doctorate Degree |
| Institut de Pharmacie Industrielle de Paris | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
CIS Bio International SA
 CIS Bio International SA Pharmaceuticals: MajorHealth Technology CIS Bio International SA engages in the distribution of radiopharmaceuticals for diagnosis and therapy. The company is headquartered in Saclay, France. | Health Technology |
OM Pharma SA
OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
Advanced Accelerator Applications (UK & Ireland) Ltd.
Advanced Accelerator Applications (UK & Ireland) Ltd. Medical SpecialtiesHealth Technology Imaging Equipment Ltd. distributes medical technologies. The firm offers PET and nuclear medical, imaging equipment, radiotherapy products, diagnostic imaging, radiation safety quality assurance, medical phantoms, ultrasound quality assurance products, molecular imaging, radiology tables, and bone densitometry products for the purpose of diagnosing osteoporosis. The company was founded in 2001 and is headquartered in Somerset, the United Kingdom. | Health Technology |
| Y-mAbs Therapeutics, Inc. | |
CUTISS AG
CUTISS AG Medical SpecialtiesHealth Technology CUTISS AG develops bioengineered skin grafts to heal people with skin defects. The company was founded by Ernst Reichmann, Martin Meuli, Daniela Marino, Clemens Schiestl and Fabienne Hartmann-Fritsch and is headquartered in Zurich, Switzerland. | Health Technology |
Evergreen Theragnostics, Inc.
Evergreen Theragnostics, Inc. BiotechnologyHealth Technology Evergreen Theragnostics, Inc. manufactures and develops radiopharmaceuticals. It offers 21 CFR 211 compliant commercial manufacturing, nationwide logistics and distribution, technology transfer and method validation and regulatory support services. The company was founded in 2019 and is headquartered in Jersey City, NJ. | Health Technology |
